How should a 13-year-old male with cerebral palsy on levetiracetam (Keppra) presenting with fever, tonsillitis, and a urinary tract infection caused by Gram-negative bacilli sensitive to ceftriaxone be managed?

Management of UTI with Concurrent Tonsillitis in a 13-Year-Old with Cerebral Palsy

Treat this patient with IV ceftriaxone for the UTI given the confirmed Gram-negative bacteremia-risk scenario, address the tonsillitis symptomatically or with appropriate antibiotics if bacterial, ensure adequate hydration, and continue Keppra with close monitoring for any neurological changes.

Immediate Antibiotic Management

For the UTI:

• Start IV ceftriaxone immediately 1. The 2024 WikiGuidelines consensus strongly recommends ceftriaxone as the empirical choice for pediatric patients requiring intravenous therapy for UTI, particularly given its low resistance rates and clinical effectiveness 1.
• The pathogen is already confirmed sensitive to ceftriaxone, making this an ideal match between empirical and definitive therapy.
• Duration: 7 days of β-lactam therapy for febrile UTI/pyelonephritis 1. Given the fever, elevated CRP (2.8), and turbid urine, this represents a febrile UTI requiring full treatment course.

Special Considerations for Cerebral Palsy:

Children with CP have significantly higher UTI rates (43.8% vs 7.5% in controls) and are prone to recurrent infections due to neurogenic bladder dysfunction 2. This patient population requires:

• Adequate hydration - critical given ceftriaxone's risk of urinary precipitates, especially in pediatric patients 3
• Monitor for urolithiasis - ceftriaxone-calcium precipitates can occur in the urinary tract, appearing as sonographic abnormalities 3
• Consider bladder management optimization to prevent recurrence

Tonsillitis Management

The tonsillitis requires separate consideration:

• If bacterial (Group A Strep suspected): Add appropriate oral antibiotic (penicillin or amoxicillin)
• If viral or mild: Supportive care with analgesics and hydration
• The ceftriaxone for UTI will NOT adequately treat typical bacterial pharyngitis/tonsillitis as it's given IV and dosing is optimized for urinary concentrations

Keppra (Levetiracetam) Considerations

Continue Keppra without interruption 4:

• No significant drug interactions with ceftriaxone 4
• However, monitor closely for fever - while rare, levetiracetam can cause drug-induced fever and eosinophilia 5. If fever persists beyond 48-72 hours despite appropriate antibiotic therapy, consider this possibility.
• Watch for neurological adverse effects (somnolence, dizziness, behavioral changes) which can occur in 12-15% of patients 4
• No dose adjustment needed for renal function unless severe combined hepatic-renal dysfunction 4

Monitoring Parameters

First 48-72 Hours:

• Clinical response: Fever curve, general appearance, hydration status
• Urine output: Ensure adequate to prevent ceftriaxone precipitation 3
• Repeat urine culture if no clinical improvement by 48 hours 6
• Neurological status: Any changes in seizure frequency or new symptoms

Laboratory:

• Prothrombin time if treatment extends beyond 5-7 days (ceftriaxone can alter PT) 3
• CBC: Monitor for hematologic changes (both Keppra and infection can affect counts) 4
• Consider renal ultrasound if oliguria or flank pain develops (ceftriaxone urolithiasis risk) 3

Transition to Oral Therapy

After 48-72 hours of clinical improvement and afebrile status:

• Switch to oral antibiotic based on culture sensitivities to complete 7-10 days total therapy 7
• Avoid fluoroquinolones unless multidrug resistance documented (reserve for specific indications in children) 2
• Options include: oral cephalosporin or TMP-SMX if sensitive

Critical Pitfalls to Avoid

1. Don't undertreate the duration: Children with CP and febrile UTI need full 7-10 day courses due to recurrence risk (up to 6.3% with inadequate therapy) 6
2. Don't assume ceftriaxone covers the tonsillitis: Treat as separate infection if bacterial
3. Don't forget hydration: Essential to prevent ceftriaxone-related urinary precipitates 3
4. Don't attribute all fever to infection: If fever persists beyond 72 hours on appropriate antibiotics, consider drug fever from Keppra 5
5. Don't stop Keppra: Seizure risk outweighs any theoretical concerns; no contraindication with ceftriaxone

Disposition

• Admit for IV therapy given age, CP diagnosis, fever, and need for hydration monitoring
• Discharge when afebrile >24 hours, tolerating oral intake, and clinically improved
• Arrange urology follow-up for bladder management optimization to prevent recurrence 2, 8